Literature DB >> 8957436

Extracorporeal circulation, hemocompatibility, and biomaterials.

G Janvier1, C Baquey, C Roth, N Benillan, S Bélisle, J F Hardy.   

Abstract

BACKGROUND: Performance of a majority of cardiac surgical procedures requires the use of extracorporeal circulation. Contact of the patients' blood with the nonendothelial surface of the cardiopulmonary bypass circuit is responsible for several, potentially harmful systemic reactions.
METHODS: The patients' response to extracorporeal circulation is reviewed briefly. The interactions between patient and circuit are discussed not only as they relate to blood-material contact, but also from a mechanical and rheologic standpoint. The theoretic benefits of the newer, more hemocompatible materials are presented, along with a review of published clinical experience with heparinized cardiopulmonary bypass circuits.
RESULTS: The response to extracorporeal circulation extends far beyond a simple derangement of hemostasis. This inflammatory response is strongly influenced by the rheologic design of the circuit and by the physical and chemical properties of the surface. Heparinized circuits decrease inflammation, but the clinical benefits of this reduction remain unclear, except for extended cardiopulmonary support. The safe use of these circuits requires full heparinization and does not reduce allogeneic transfusions.
CONCLUSIONS: Clinicians are still in the search of the ideal material and the ideal extracorporeal circuit design. Newer, heparinized materials offer real but limited clinical benefits.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8957436     DOI: 10.1016/s0003-4975(96)00942-3

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

Review 1.  VV extracorporeal life support for the Third Millennium: will we need anticoagulation?

Authors:  Danny Eytan; Yuval Bitterman; Gail M Annich
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

2.  Clinical evaluation of poly(2-methoxyethylacrylate) in primary coronary artery bypass grafting.

Authors:  See N Vang; Chad P Brady; Kevin A Christensen; Jack R Isler; Keith R Allen
Journal:  J Extra Corpor Technol       Date:  2005-03

3.  Nafamostat mesilate modulates the release of platelet-activating factor during left ventricular assistance with hemofiltration in canine heart failure.

Authors:  M Munakata; Y Ono; M Koyama; K Fukui; K Satoh; S Suzuki
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-02

Review 4.  Development and hemocompatibility testing of nitric oxide releasing polymers using a rabbit model of thrombogenicity.

Authors:  Terry C Major; Hitesh Handa; Gail M Annich; Robert H Bartlett
Journal:  J Biomater Appl       Date:  2014-06-16       Impact factor: 2.646

Review 5.  Tailored carbon nanotubes for tissue engineering applications.

Authors:  Jithesh V Veetil; Kaiming Ye
Journal:  Biotechnol Prog       Date:  2009 May-Jun

6.  In vivo evaluation of the biocompatibility of surface modified hemodialysis polysulfone hollow fibers in rat.

Authors:  Ganpat J Dahe; Sachin S Kadam; Siddharth S Sabale; Dattatray P Kadam; Laxman B Sarkate; Jayesh R Bellare
Journal:  PLoS One       Date:  2011-10-25       Impact factor: 3.240

7.  A novel minimal invasive mouse model of extracorporeal circulation.

Authors:  Shuhua Luo; Menglin Tang; Lei Du; Lina Gong; Jin Xu; Youwen Chen; Yabo Wang; Ke Lin; Qi An
Journal:  Mediators Inflamm       Date:  2015-01-29       Impact factor: 4.711

Review 8.  The Roles of Membrane Technology in Artificial Organs: Current Challenges and Perspectives.

Authors:  Bao Tran Duy Nguyen; Hai Yen Nguyen Thi; Bich Phuong Nguyen Thi; Dong-Ku Kang; Jeong F Kim
Journal:  Membranes (Basel)       Date:  2021-03-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.